Fenugreek: an Emergent Allergen
Fenugreek: New Therapeutic Resource or Emerging Allergen
1 other identifier
observational
15
1 country
1
Brief Summary
Fenugreek or Trigonella foenum greacum is an ancient medicinal plant native to the eastern Mediterranean, later spread to Asia (especially in India); it belongs to Rosaceae order, Leguminosae family, subfamily of Papilonaceae and it is used as a medicinal herb, spice or food. It is a component of spice mix, such as curry, and it is also used as a supplement in wheat and corn flour for bread-making. Fenugreek appears to have many health benefits and potential medicinal properties (antioxidant, antidiabetic, hepatoprotective, hypocholesterolemic, antimicrobial, anti-inflammatory, neuroprotective, anticarcinogenic, antiulcer, and antilithigenic) both in vitro and in vivo studies; for this reason it may be increasingly being used as nutraceutical formulations (powder, herbal teas, tablets and various combinations).This study aims to describe patients who came to our operating unit for suspected adverse reaction after ingestion of fenugreek and to highlight possible cross-reactivity between fenugreek and other legumes or other foods. Given the increasing use of novel spices in Mediterranean cuisine and the possible spread of fenugreek-based nutraceuticals, it is relevant to draw attention to possible allergic reactions.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started Jan 2022
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2023
CompletedFirst Submitted
Initial submission to the registry
February 1, 2024
CompletedFirst Posted
Study publicly available on registry
February 14, 2024
CompletedFebruary 14, 2024
February 1, 2024
2 years
February 1, 2024
February 13, 2024
Conditions
Outcome Measures
Primary Outcomes (1)
Cutaneous sensitization to fenugreek
Cutaneous sensitization to fenugreek evaluated by the result of skin prick test in patients with suggestive history of allergic reactions to spices.
1 hour
Secondary Outcomes (1)
Cross-reactivity between fenugreek and other legumes and other foods
1 hour
Study Arms (2)
Allergic patients to fenugreek
Non allergic patients to fenugreek
Interventions
Fenugreek wiil be tested by mixing fenugreek seed powder with saline at non-irritating doses and it will be performed by prick-by-prick test. The skin tests will be read 20 minutes after the execution.
Eligibility Criteria
All patients referred to outpatients visit to the Operative Unit of Allergy and Clinical Immunology of Messina University Hospital with a suggestive history of allergy after ingestion of spices and tested for fenugreek.
You may qualify if:
- age \> 18 yo
- history of allergic reactions to spices
- history of allergic reactions to phytotherapics containing fenugreek
You may not qualify if:
- age \< 18 yo
- non suggestive history of allergic reactions to spices
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Paola Miciullolead
Study Sites (1)
AOU Policlinico Universitario G. Martino
Messina, Sicily/Messina, 98124, Italy
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Associated Professor
Study Record Dates
First Submitted
February 1, 2024
First Posted
February 14, 2024
Study Start
January 1, 2022
Primary Completion
December 31, 2023
Study Completion
December 31, 2023
Last Updated
February 14, 2024
Record last verified: 2024-02